Karen Anderson, Professor, Arizona State University, Mayo Clinic Arizona

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Merck
    Topic: 
    pembrolizumab
    Date added: 
    12/21/2023
    Relationship end date: 
    03/31/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Effector
    Topic: 
    therapeutics
    Date added: 
    12/21/2023
    Relationship end date: 
    12/05/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Stock Options
    Ineligible company: 
    FlexBioTech
    Topic: 
    molecular diagnostics
    Date added: 
    12/21/2023
Return to Binaytara Hematology and Breast Cancer Conference, Fresno